Sorrento OK'd For Alternative $110M Ch. 11 Stock Sale

By Emily Lever · September 12, 2023, 10:30 PM EDT

Bankrupt drug developer Sorrento Therapeutics received a Texas court's approval Tuesday for subsidiary Scilex Holding Co. to buy its own stock back from its parent for $110 million after the original...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Sorrento Therapeutics, Inc. and Official Committee of Unsecured Creditors

Case Number

4:23-bk-90085

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023